Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants
29 Mai 2009 - 3:20PM
PR Newswire (US)
DALLAS, May 29 /PRNewswire/ -- BeaconEquity.com announces
availability of alerts on pharmaceutical companies poised to wrap
up the week with heavy trading. The alerts include recent news,
trading activity and technical analysis. Investors can view all of
the daily stock alerts for free by visiting BeaconEquity.com/m.
Today's Stock Alerts include: Angiotech Pharmaceuticals Inc.
(NASDAQ: ANPI), Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM),
Biogen Idec Inc. (NASDAQ:BIIB), Genzyme Corp. (NASDAQ:GENZ),
Celgene Corp. (NASDAQ:CELG) and Gilead Sciences Inc. (NASDAQ:GILD).
Join the fastest growing investment community at:
http://www.stockhideout.com/ See what Cramer has to say about these
stocks and many more. BeaconEquity.com's Stock Alerts are brief
analyses on the active stocks each day that are affecting the
markets. These include breaking news, insider activity, recent
52-week highs/lows, technical breakouts, and other market driving
information. Beacon is the authority on research in the small-cap
sector, and our analysts strive each day to find the stocks that
are poised to be the biggest movers before the rest of the market
is aware of them. We encourage investors to subscribe to our FREE
newsletter filled with daily trading ideas. BeaconEquity.com is one
of the industry's largest small-cap research providers. Beacon
strives to provide a balanced view of many promising small-cap
companies that would otherwise fall under the radar of the typical
Wall Street investor. We provide investors with an excellent first
step in their research and due diligence by providing daily trading
ideas, and consolidating the public information available on them.
For more information on Beacon Research, please visit:
http://www.beaconequity.com/m CRD# 2207572 BeaconEquity.com
Disclosure BeaconEquity.com is not a registered investment advisor
and nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. BeaconEquity.com is a
Web site wholly-owned by BlueWave Advisors, LLC. Please read our
report and visit our Web site, BeaconEquity.com, for complete risks
and disclosures. Beacon Equity Research Jeff Bishop, (469)-252-3505
David C. Masson of Beacon Equity Research is a member of the
National Association of Securities Dealers, CRD number 2207572.
Available Topic Expert(s): For information on the listed expert(s),
click appropriate link. JEFF BISHOP
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781
DATASOURCE: BeaconEquity.com CONTACT: Jeff Bishop of Beacon Equity
Research, +1-469-252-3505, Web Site:
http://www.beaconequityresearch.com/
Copyright